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Abstract
The CCN family of genes consists presently of six members in human (CCN1-6) also known as
Cyr61 (Cystein rich 61), CTGF (Connective Tissue Growth Factor), NOV (Nephroblastoma
Overexpressed gene), WISP-1, 2 and 3 (Wnt-1 Induced Secreted Proteins). Results obtained over
the past decade have indicated that CCN proteins are matricellular proteins, which are involved in
the regulation of various cellular functions, such as proliferation, differentiation, survival, adhesion
and migration. The CCN proteins have recently emerged as regulatory factors involved in both
internal and external cell signaling. CCN3 was reported to physically interact with fibulin-1C,
integrins, Notch and S100A4. Considering that, the conformation and biological activity of these
proteins are dependent upon calcium binding, we hypothesized that CCN3 might be involved in
signaling pathways mediated by calcium ions.
In this article, we review the data showing that CCN3 regulates the levels of intracellular calcium
and discuss potential models that may account for the biological effects of CCN3.
Review
Introduction
The control of normal cell biology, from life to death
involves an extremely complex array of interconnected
signaling pathways, which govern inward and outward
communication. Over the two past decades, a plethora of
proteins have been found to participate in these funda-
mental regulatory circuits. In most cases, alterations of sig-
naling result in pathological conditions. For example,
many of the proteins discovered as oncogenes and tumor
suppressors in cancer cells were shown to be key signaling
molecules.
Signaling is pivotal to the coordinated response of cells in
tissues and organs within the whole body. It is often con-
sidered that cell populations function as « societies » and
that intercellular communication is pivotal to harmoni-
ous development during life and to intracellular biologi-
cal modifications leading to cell death. Efficient
coordination is an absolute requirement to safe
functioning
It is critical to study and understand cross talking in cell
population and to identify messengers that allow inte-
grated responses. Unfortunately, very little is known pres-
ently about the processes that coordinate the various
cellular signaling pathways.
An increasing amount of data points to matricellular pro-
teins as major players in global control. Members of the
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CCN family of proteins have recently emerged as impor-
tant matricellular regulatory factors involved in both
internal and external cell signaling.
The CCN family of proteins
Bork coined the CCN acronym in 1993 [1], soon after our
discovery of a new gene –nov– presently designated CCN3
[2] whose expression was enhanced in all myeloblastosis
associated virus (MAV)-induced nephroblastomas [3],
which represent a unique animal model of the Wilms'
tumor in human [4].
Analysis of the predicted primary structure of CCN3 indi-
cated that it was structurally related to two other proteins
(CYR61/CCN1 and CTGF/CCN2) that had been previ-
ously described as « immediate early » proteins showing
mitogenic activities. The concept of a protein family was
sustained by the fact that these three proteins were sharing
a common mosaic organization with four structural mod-
ules sharing identity with Insulin like growth factor (IGF)-
binding proteins (IGFBPs), Von Willebrand factor type C
repeat, thrombospondin type 1 repeat, and secreted regu-
latory factors containing a cystin knot motif involved in
dimerization.
The discovery of CCN3 provided the first evidence for a
member of the CCN family of proteins showing antipro-
liferative activity on chicken embryo fibroblasts (CEF).
Interestingly, the aminotruncated version of CCN3
expressed in one MAV-induced nephroblastoma was stim-
ulating growth and inducing morphological transforma-
tion of the CEF [3].
Since then, three new members of the CCN family have
been identified. CCN4 and CCN5, which were originally
designated elm1 and rCOP1 respectively [5,6], were also
described as rodent proteins devoted of an antiprolifera-
tive activity. Their human counterpart were identified a
few years later as WINT-induced secreted proteins (WISP),
with a new member (CCN6) originally identified from
EST libraries and designated WISP3.
All CCN proteins except CCN5 – which lacks the CT mod-
ule – show a similar multimodular organization.
The ccn genes are expressed in a wide variety of tissues.
Expression of CCN proteins has been associated to several
fundamental biological processes such as angiogenesis,
chondrogenesis, wound healing [7–9]; their expression is
detected during muscular differentiation, nervous system
development and bone remodeling with an enhancement
of CTGF correlated to several fibrotic situations [7–9].
Aberrant ccn gene expression is also associated to tumori-
genesis [10], and has been shown to provide useful mark-
ers for tumor typing and prognosis.
Considering the variety of sometimes opposite biological
functions attributed to the CCN proteins and the tight
spatio-temporal regulation of their expression in many
tissues of different origins, we proposed that the CCN pro-
teins interact with several different partners and that the
resulting combinatorial events are responsible for the
variety of their functions [7].
CCN3 interacts with several different proteins
To identify the potential partners of CCN3, we first used
the yeast two-hybrid strategy [11,12]. Two types of consid-
erations dictated our choice of the full length CCN3 pro-
tein as bait. Firstly, each individual module was
potentially interacting with several factors whose partici-
pation is essential to the biological functions of the fami-
lies of proteins that contain these modules. Therefore,
interaction with many of the potential interactions taking
place with individual modules might not be directly rele-
vant to the functions of CCN3. Secondly, and more
importantly, some interactions critical for the functions of
CCN3 might require the tertiary structure of the full-
length protein.
Several different proteins were found to physically interact
with CCN3 in the yeast assay especially fibulin-1C,
integrins, Notch and S100A4 [7]. The physical interaction
of CCN3 with these proteins has been checked either by
GST-pull down assay, co-immunprecipitation, co-immu-
nolocalization, or functional interdependence. The pro-
teins interacting with CCN3 were either secreted, or
localized in the cytosol, or localized in the nucleus of var-
ious cell types.
In as much as the conformation and biological activity of
fibulin-1C, integrins, Notch and S100A4 were dependent
upon calcium, we hypothesized that CCN3 might be
involved in signaling pathways involving calcium ions.
Considering the considerable importance of calcium as a
second messenger, these observations open new avenues
for understanding the role of CCN proteins in cell growth
regulation.
CCN3-Fibulin-1C and calcium
Yeast two-hybrid screens indicated that CCN3 interacted
with the calcium-binding extracellular matrix glycopro-
tein fibulin-1C [11]. Fibulin-1C is associated with various
connective tissues, basement membranes and blood; it
was also reported to interact with extracellular matrix pro-
teins such as fibronectin, laminin, and fibrinogen [13].
Although a distinct function for fibulin-1C has not yet
been described, evidence has emerged to indicate that it
may regulate cell adhesion and migration along protein
fibers within the extracellular matrix and play a role in
homeostasis and thrombosis [14]. Moreover, fibulin-1CCell Communication and Signaling 2003, 1 http://www.biosignaling.com/content/1/1/1
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exhibits calcium-dependent binding and its functions
were reported to dependent upon the calcium binding
[11].
The identification of an interaction between fibulin-1C
and CCN3 provides clue for possible interaction of CCN
in signaling pathways involving extracellular matrix,
cytoskeleton proteins and calcium. The C-terminal part of
CCN3 is involved in the interaction with fibulin-1C. Trun-
cated recombinant protein that represented only the C-
terminal portion of CCN3 was able to interact with fibu-
lin-1C. Similar to CCN3, fibulin-1C has a multimodular
structure and contains a portion of nine calcium-binding
type II EGF-like modules [13]. Using these modules, fibu-
lin-1C is able to interact with the extracellular domain of
the heparin-binding EGF-like growth factor precursor sug-
gesting an important role during extracellular matrix for-
mation in wound healing [15]. Binding of CCN3 to
fibulin-1C involves this EGF-like module as previously
reported for fibronectin [16]. This interaction might
induce modification in calcium levels in the neighbor-
hood of the cells.
CCN3 – Integrins and calcium
Integrins are cell surface receptors that are involved in
adhesive interactions. They interact with several extracel-
lular matrix proteins and other cell surface receptors.
Integrins are heterodimeric transmembrane proteins that
are composed of non-covalently associated α and β subu-
nits [17]. The activation of integrins has been associated
with conformational changes in the extracellular
domains, which leads to an increased affinity for the lig-
and binding. Integrin-ligand interactions are dependent
upon divalent cations. Some cations can enhance the
affinity for the ligand, while others can suppress or lower
it. For many integrins, Mg2+ and Mn2+ can induce confor-
mational changes associated with a higher affinity for the
ligand. On the contrary, Ca2+ often has an inhibitory effect
on ligand binding. For instance, for integrin αvβ3, the
increase in affinity for the ligand mediated by Mg2+ needs
the chelation of Ca2+ [18].
It has been shown that extracellular Ca2+ can modulate the
function of integrins but the Ca2+  binding sites on
integrins are poorly characterized. To date, two distinct
classes of Ca2+ binding sites were identified on integrins: a
low and a high affinity-binding site for Ca2+. For integrins
α5β1 and β3, a high affinity site for Ca2+ promotes the
binding to the ligand, and a low affinity site seems to
compete with a Mg2+ site [19,20]. Studies on integrin
αIIbβ3 suggested that a high affinity Ca2+ site is involved in
the heterodimerization of the two subunits. Since several
integrins exhibit a high affinity Ca2+ binding site, this sug-
gests a possible common role in heterodimerization of
the two subunits. Furthermore, the binding of Ca2+ to a
high affinity site seems to be necessary for ligand binding.
It was recently shown that CCN3 physically interacts with
integrins αVβ3 and α5β1 [21]. CCN3 acts on endothelial
cells to stimulate pro-angiogenic activities, and supports
cell migration and adhesion through different cell surface
receptors including integrins αVβ3, α6β1 and α5β1. Extra-
cellular Ca2+ could modulate CCN3-integrins interactions
and thus, play a role in the functions of CCN3 in
angiogenesis.
Intracellular Ca2+  is also involved in the intracellular
integrin-pathways leading to integrin-mediated adhesion
(for review [22]). The Ca2+ increase induced by the activa-
tion of integrins by their ligands [23] can activate the pro-
tease calpain. Studies on migrating CHO cells transfected
with β1 and β3 integrins suggest that the Ca2+-activated
calpain could be involved in the dissociation between
integrins and cytoskeleton, and thereby could influence
the binding of integrins to their ligands. Since CCN3
modulates the Ca2+ influx in some cells, CCN3 could also
acts on integrins function in an indirect manner by acti-
vating the calpain protease via Ca2+ entry. It would be of
prime interest to determine if CCN3 modifies the Ca2+
influx in endothelial cells that could be linked to the
migration of these cells.
CCN3 – Notch and calcium
CCN3 has been found to interact with Notch1 and to acti-
vate downstream effectors of the Notch pathway [24].
Notch1 is a member of a family of highly conserved trans-
membrane receptors, which are involved in fundamental
biological processes during embryonic development such
as differentiation, proliferation and apoptosis [25].
Notch receptors are synthesized in the form of an approx-
imatively 300 to 350 kDa transmembrane precursor. This
single protein is cleaved in the trans-Golgi network to
form a heterodimeric receptor, consisting of a N-terminal
extracellular subunit and a C-terminal transmembrane
domain [25]. The extracellular subunit of various Notch
receptors contains several tandemly repeated EGF (Epi-
dermal growth Factor) modules. The N-terminal part of
the receptor acts to restrain receptor activation in absence
of ligand, and the structural integrity of the EGF repeats is
dependent upon the presence of Ca2+. The N- and C-ter-
minal parts of the Notch heterodimer are non-covalently
associated [26]. The association is stabilized in the pres-
ence of Ca2+ and destabilized by EDTA, resulting in the
activation of Notch target genes [26]. These results suggest
a regulation of the Notch activity implying a Ca2+-depend-
ent interaction between the extracellular and the trans-
membrane parts of the Notch receptor, prior to activation.Cell Communication and Signaling 2003, 1 http://www.biosignaling.com/content/1/1/1
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Although CCN3 physically interacts with the EGF-like
repeats of Notch1, this binding is Ca2+-independent, since
co-immnunoprecipitation of CCN3 and Notch1 was
maintained in buffer without Ca2+ and in buffer contain-
ing EGTA [24].
CCN3-S100A4 and calcium
Our recent studies demonstrated that CCN3 physically
interacts with the calcium binding protein S100A4 [27].
This provides a clue for the detection of CCN3 at sites
where S100A4 was reported to be expressed in normal
conditions and where calcium is known to play critical
roles.
S100A4 belongs to the group of S100 proteins, one of the
largest subfamilies of the EF-hand proteins, which bind
calcium selectively and with high affinity [28,29]. The
S100 proteins are thus thought to modulate the propaga-
tion of calcium signals [30]. The human S100A4 gene was
reported to be frequently rearranged through deletions,
duplications and translocations, and is altered in several
cancers [31]. Recently, interest has focused on S100A4
due to its implication in tumor progression and
metastasis.
Binding of calcium to S100A4 proteins induces conforma-
tional changes, which result in exposure of new binding
sites at their surface, and consequently allows for interac-
tion with target proteins [32]. Thus, the interaction of
CCN3 with S100A4 might be dependent upon local intra-
cellular calcium concentration. The interaction of CCN3
with S100A4, as revealed with the yeast two hybrid system
and GST pull down assay in vitro, strongly suggests that
these two proteins can interact in vivo [27]. In support to
this hypothesis, studies performed with CCN3 and
S100A4 indicated that their site of expression showed sig-
nificant overlap [7,33–36].
Involvement of CCN3 and S100A4 in tumorigenesis
CCN3 is expressed in many different types of tumors and
shows positive or negative effects on tumorigenesis and
metastasis [10]. On the other hand, the elevated expres-
sion of S100A4 in tumor metastasis suggests a role in
tumor progression [37]. Since S100A4 itself is not able to
initiate tumors, it was proposed that it might act in coop-
eration with other oncogenes [38]. The interaction of
CCN3 with S100A4 makes it interesting to check whether
these two proteins act in synergy or antagonize during
tumorigenesis.
In one hand, CCN3 proteins were detected in the extracel-
lular matrix, conditioned cell culture medium, cytoplasm
and nucleus [7,10,12], in the other hand, S100A4 has
been essentially described as a cytoplasmic protein,
although it was also found to be secreted [39]. These
results therefore suggest that CCN3-S100A4 could interact
intra and extra cellularly, and that this interaction might
be critical during development, both in physiological and
pathological conditions.
Biological effects of CCN3-S100A4 interaction
S100A4 protein is now known to be involved in the regu-
lation of cell motility and cell cycle progression, intercel-
lular adhesion, angiogenesis, and metastatic properties of
cancer cells. The interaction of CCN3 with S100A4 should
therefore be helpful in deciphering the biological function
of CCN3 and extends the roles of CCN proteins to S100
family.
Regarding cell motility, CCN3 was reported to decrease
the adhesive capacity and increase the motility of Ewing's
transfected cells [40]. It was suggested that S100A4 pro-
tein affects the assembly of the cytoskeleton [41,42].
These findings suggest that CCN3, through its interaction
with S100A4, might alter cytoskeletal organization and
facilitate cell motility.
The expressions of S100A4 and E-cadherin, which sup-
press tumor invasion, were reported to be inversely regu-
lated in a series tumor cell lines [43]. It was suggested that
the invasiveness of tumors expressing S100A4 might be at
least partially induced by the abrogation of E-cadherin
expression [44]. The interaction of CCN3 with S100A4
sheds new light on the potential role of CCN proteins as
matricellular regulators of cell proliferation. Down-regu-
lation of S100A4 resulted in a decrease in metalloprotein-
ases expression and consequently in a reduction in
migration process [45,46]. The interaction of CCN3 with
S100A4 suggests that CCN3 might also be involved in the
dysregulation of metalloproteinases expression, and may
participate in a large array of connections involving sev-
eral different proteins of the extracellular matrix.
Recently, an association between S100A4 and cell prolif-
eration has been postulated. S100A4 expression was asso-
ciated with elevated levels of wild-type p53. It was
suggested that the physical interaction between wild-type
p53 and S100A4 might result in a stimulation of the cells
to enter the S phase [47,48]. The transfection of S100A4-
negative cells with S100A4 constructs led to clonal death
that was prevented by co-transfection with the anti-apop-
totic gene bcl-2, which control calcium entry in different
subcellular compartments [49]. CCN3-S100A4 interac-
tion raises the possibility that CCN3 might promote
apoptosis through its interaction with the S100A4-p53
complex. This would provide a clue (an explanation) for
the dual role of CCN3 in proliferation and differentiation
[6].Cell Communication and Signaling 2003, 1 http://www.biosignaling.com/content/1/1/1
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Recent findings established that CCN3 acts directly upon
endothelial cells to stimulate pro-angiogenic activities,
and induces angiogenesis in vivo [21]. Interestingly,
S100A4 also promotes angiogenesis in vivo by preventing
the anti-angiogenic effect of THBS1 [50]. In addition, pre-
liminary results suggest that S100A4 protein may act
directly as an angiogenic factor [51]. Whether CCN3 pro-
motes angiogenesis directly, through its interaction with
S100A4 or otherwise remains unclear.
CCN3-S100A4 interaction provides another pathway for
stimulating calcium entry induced by CCN3: S100A4
could modulate cellular calcium levels via its roles in cal-
cium uptake, transport and buffering [52]. The CCN3-
S100A4 interaction might change the affinity of S100A4
for calcium and cause a release from S100A4. Because of
its limited binding capacity for calcium, S100A4 might
not be the main effector of calcium increase in cell upon
induction by CCN3. In conclusion, the interaction of
CCN3 with S100A4 might account at least in part for the
association of CCN3 with tumorigenesis and metastasis.
CCN3 and calcium signaling
Because CCN3 is expressed in various tissues where the
calcium metabolism and ion transport are essential [7]
and that it physically interacts with proteins whose activ-
ity depended on calcium binding, we hypothesized that
CCN3 might have a direct action on intracellular calcium
mobilization. We used dynamic intracellular calcium
fluorimetry [53] to examine the potential role of CCN3 in
affecting intracellular calcium level in human tumoral
cells (fig. 1).
The application of CCN3 resulted in a transient increase
of the intracellular calcium concentration in G59 glioblas-
toma cells (fig. 1A). The control GST protein alone was
without effect on the intracellular calcium level (data not
shown). A similar transient increase in calcium was also
seen with human neuroblastoma SK-N-SH cells upon
CCN3 delivery [27]. In these experimental conditions, the
calcium response reached a maximum and sustained
effect (fig. 1B). Toxic effects (including the cells blowing
up) were seen when higher concentrations of the GST
fusion protein were used. To determine the origin of this
transient calcium increase, experiments were carried out
in the absence of extracellular calcium. Under these con-
ditions, lower transient calcium increase in G59 cells per-
sisted (fig. 1C). Furthermore, the addition of calcium to
EGTA containing medium induced a sustained increase of
intracellular calcium, suggesting a mixed interaction of
CCN3 with the stimulation and release of intracellular
calcium from the internal store and with the entry of
extracellular calcium in G59 cells (fig. 1D). The addition
of blockers of voltage-dependant calcium and/or sodium
channels (verapamil and flunarizine) did not modify the
transient calcium increase induced by GST-CCN3 in this
cell line [27]. Finally, no increase was induced by the GST-
fibulin-1C fusion protein, which contained the portion of
fibulin-1C interacting with CCN3 [11] (fig. 1E). Con-
versely, a transient increase in intracellular calcium was
also induced when another member of CCN family, GST-
CCN2, was applied to G59 cells, but the effect of CCN2
was slightly lower than that of CCN3 at the same dose (fig.
1F). The presence of fibulin-1C or CCN2 did not modify
the calcium response induced by CCN3, suggesting that
these proteins did not compete with CCN3.
An interesting aspect of the relation between CCN3 func-
tion and calcium signaling was raised by the pronounced
increase in intracellular calcium concentration, which was
transiently induced in CCN3 treated G59. In these cells,
both entry and the mobilization of the internal calcium
store were induced by the addition of CCN3. Because the
inhibitory effect of EGTA upon the calcium increase was
reversed after the addition of CaCl2, CCN3 is unlikely to
be an ionophore by itself.
The uptake of extracellular calcium induced by CCN3 pro-
ceeded even when voltage dependent channels were
blocked. Therefore, it is tempting to speculate that it
involves store operated calcium channels, a heterogene-
ous subset of plasma membrane calcium ion channels.
The best characterized channel of this type was originally
described in mast cells in which the depletion of calcium
induced a sustained calcium inward current that was not
voltage activated and therefore termed ICRAC (for calcium
release activated calcium) [54–56]. A direct stimulation of
these channels or of transient receptor potential (TRP)
family of non-selective cation channels [57] could be pos-
tulated as a possible mode of action of CCN3.
The mobilization of intracellular calcium stores by CCN3
in G59 cells might involve specific receptors and IP3 acti-
vated channels. The transient calcium increase induced by
CCN3 is sufficient to activate potassium current (BK/Ca) as
recorded by whole-cell patch clamp on G59 cells (unpub-
lished data). Along this line, the interaction of CCN1,
CCN2, and CCN3 proteins [58–60] with integrins might
be of relevance to induce a transient increase of intracellu-
lar calcium.
As discussed above, CCN3 can interact with fibulin-1C
and Notch1. It will be interesting to determine whether
the regulation of intracellular calcium concentrations by
CCN3 affects in any way its association with these pro-
teins and their biological activities.
The interaction of CCN3 with S100A4 and its ability to
induce a transient increase of intracellular calcium by twoCell Communication and Signaling 2003, 1 http://www.biosignaling.com/content/1/1/1
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different mechanisms add another degree of variety to the
pleiotropic biological properties of the CCN proteins.
A growing body of evidence indicates that CCN3 is impli-
cated in many fundamental aspects of cellular activity.
Our observations suggest for the first time that CCN pro-
teins functionally crosstalk with calcium related physio-
logical and pathological processes and open new
perspectives in understanding the functions of CCN pro-
teins in normal and pathological conditions. The interac-
tion of CCN3 protein with numerous potential partners
Effect of CCN proteins on intracellular calcium levels in G59 glioblastoma cells Figure 1
Effect of CCN proteins on intracellular calcium levels in G59 glioblastoma cells. GST-CCN3 (2 µg/ml, Fig. 1A or 10 
µg/ml, Fig. 1B) was applied on G59 cells in the absence of EGTA. In the presence of 10 mM EGTA, GST-CCN3 (2 µg/ml) was 
added (Fig. 1C) and 12 mM CaCl2 was overloaded (Fig. 1D). The effects of fibulin-1C and GST-CCN2 (5 µg/ml) were com-
pared to that of 5 µg/ml GST-CCN3 (Fig. 1E,1F)Cell Communication and Signaling 2003, 1 http://www.biosignaling.com/content/1/1/1
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could explain the multiplicity of functional implications
of CCN3 in cellular calcium signaling.
The multimodular organization of the CCN proteins pro-
vides a structural base that may account for its interaction
with different target proteins. This type of multimodular
organization is not unique to the CCN proteins. For exam-
ple, the Caspase proteins family also show a modular
organization [61]. They contain different domains (DD,
CARD, etc.) that can be bound by adaptative proteins
such as FADD and Apaf-1 [62] or BAR [63], which are
involved in controlling apoptosis.
The regulation of intracellular calcium levels can be
achieved by several ways. Recently, a PKC binding protein
– enigma homolog (ENH)- has been reported to specifi-
cally interact with both PKCε and N-type Ca2+ channels,
thereby forming a PKCε-ENH-Ca2+ channel macromo-
lecular complex [64] that facilitated modulation of N-type
Ca2+ channel activity by PKC.
The increased intracellular calcium level induced by
CCN3 might also involve different voltage-independent
calcium channels, among which receptor operated cal-
cium channel and capacitative calcium entry channel may
be of considerable importance in regulating this calcium
influx.
Schematic representation of different signaling pathways that may account for the calcium-related functions of CCN3 Figure 2
Schematic representation of different signaling pathways that may account for the calcium-related functions 
of CCN3. 1. Activation of GPCRs 2. Binding to integrins 3. Opening of voltage-independent calcium channels 4. Interaction 
with calcium binding proteins inside the cell 5. Modification of the calcium status inside the nucleus and modulation of gene 
expression
Ca++
R
G
PLC
GPCR
CCN3
INT
Ca++
CCN3
nucleus
IP3
Ca++
E.R
CCN3
CCN3
CCN3
S100A4
CaCh
1
2
3
4
5Cell Communication and Signaling 2003, 1 http://www.biosignaling.com/content/1/1/1
Page 8 of 10
(page number not for citation purposes)
Conclusions
We have hypothesized [7] that CCN3 might function as
an adaptative protein by interacting with different regula-
tory proteins. Thus, CCN3 was proposed to coordinate
signaling pathways by bringing together regulators, which
require calcium for their biological effects.
In figure 2 we have summarized non-exclusive possible
pathways that may account for the calcium-related func-
tions of CCN3.
In the first case, CCN3 is shown to interact with members
of the G Protein-Coupled Receptors (GPCR) family whose
activation is known to result in Inositol 1,4,5-triPhos-
phate (IP3) production and calcium release from endo-
plasmic reticulum. IGFBPs were recently reported to
specifically recognize these receptors and induce a tran-
sient increase of intracellular calcium [65]. The possibility
that the IGFBP module is responsible for its effects on cel-
lular calcium is under current investigation.
The second pathway by which CCN3 could induce the cal-
cium increase involves binding to integrins. Effects of
integrins on calcium have been extensively documented.
The physical interaction of CCN3 with integrins makes it
a major possibility.
In the third case, interaction of CCN3 with voltage-inde-
pendent channels would lead to an uptake of calcium
from external sources. As discussed above, store operated
channels are among the likely candidates.
The fourth level of action would imply S100A4 whose
physical interaction with CCN3 might interfere with its
ability to bind calcium ions and play its buffer functions.
We are presently in process of determining whether other
proteins of the S100 family are also interacting with
CCN3.
In the fifth case, translocation of CCN3 to the nucleus
[66], is thought to account for the detection of the trun-
cated CCN3 nuclear isoforms [12]. The importance of cal-
cium in the regulation of gene expression is well
established. It has been proposed that CCN3 play a direct
role in the regulation of transcription by interacting with
the rpb7 subunit of RNA polymerase II [12]. The levels of
intracellular calcium ions might therefore be a key factor
in controlling the interactions of CCN3 with its nuclear
partners.
In any case, the links that we have established between
CCN proteins and calcium signaling opens new avenues
that should help to decipher the role of these regulatory
proteins in processes governing cell growth control, devel-
opment, and normal and pathological physiology.
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